ARCHIVES

Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

NCI awards $42 million for prevention trials consortium.

December 5, 2003

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

Hood’s ISB Gets $5 Million From Merck, Hires Scientists.

September 1, 2000

Vasectomy Doesn’t Increase Prostate Cancer Risk

July 26, 2002

ONS Meeting Again With ASCO And AACR In San Francisco

April 28, 1989